Q . TELL US ABOUT DORNAN GROUP AND KEY STRATEGIES FOR 2021 / 22 ?
» We are one of the largest specialist construction firms in Europe . Despite the challenges of COVID-19 , we posted a record turnover of € 486mn in 2020 , up from € 332mn in 2019 . Dornan Group now has its eyes on further growth for 2021 and beyond , with a specific focus on the rapidly growing pharmaceutical sector . With long-standing expertise in this sector , Dornan is placing a renewed focus on its European pharmaceutical operations wing , further strengthening its capabilities to provide innovative solutions to existing and future clients . We have already made a number of strategic hires in the last year to support our ambitious growth plans .
€ 486mn
We posted a record turnover of € 486mn in 2020 , up from € 332mn in 2019
Q . SPECIFICALLY , IN PHARMA , EXPLAIN WHAT THE NEW EUROPEAN PHARMACEUTICAL OPERATIONS WING OFFERS TO CLIENTS ?
» The pharmaceutical sector has experienced rapid growth in recent years , and we anticipate a significant investment within Europe over the next five years in projects ranging from biotech to fill-finish , API , and cell & gene therapy as well as blood fractionation and vaccines . Dornan Group was one of the first Irish construction companies to expand into Europe almost 15 years ago , and we ’ re now looking to use Ireland as a base to grow our pharmaceutical client base in Europe and Switzerland , having recently won another large project in Belgium with a global biopharma company , focusing on neurology and
constructionglobal . com 21